Skip to main content

Advertisement

Log in

Potential Value of Estrogen Receptor Beta Expression in Colorectal Carcinoma: Interaction with Apoptotic Index

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Purpose

The study was designed to investigate the clinicopathological correlations, relationship to apoptotic index, and prognostic significance of estrogen receptor beta expression in colorectal carcinoma.

Methods

The study was carried out on 40 patients with newly diagnosed colorectal cancer. The patients’ data were collected prospectively and the 2 years overall survival was the endpoint. Estrogen receptor beta expression was assessed by immunohistochemistry. Apoptotic body index was calculated by counting apoptotic cells using the modified TUNEL assay.

Results

Estrogen receptor beta positivity was detected in 65% of colorectal cancer cases, while estrogen receptor alpha positivity was found in only 7% of cases. The rate of estrogen receptor beta immunoreactivity was significantly higher in low-grade colorectal tumors. The median apoptotic index in estrogen receptor beta positive cases was significantly higher than in estrogen receptor beta negative cases (6% versus 3%; p = 0.01). The median overall survival was higher in estrogen receptor beta positive cases (22 versus 18 months); however, the difference was not statistically significant.

Conclusions

The study results reinforce the importance of the estrogen receptor beta rather than the estrogen receptor alpha in colorectal cancer. Lack of estrogen receptor beta expression is associated with loss of differentiation and decreased apoptosis. Future studies should include validation of estrogen receptor beta as a prognostic marker and exploration of its role as a target in the management of colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM, et al. The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer. Cancer. 2000;88(10):2398–424.

    Article  PubMed  CAS  Google Scholar 

  2. Kennelly R, Kavanagh DO, Hogan AM, Winter DC. Oestrogen and the colon: potential mechanisms for cancer prevention. Lancet Oncol. 2008;9(4):385–91.

    Article  PubMed  CAS  Google Scholar 

  3. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative Randomized Controlled Trial. JAMA. 2002;288(3):321–33.

    Article  PubMed  CAS  Google Scholar 

  4. Ascenzi P, Bocedi A, Marino M. Structure–function relationship of estrogen receptor alpha and beta: impact on human health. Mol Aspects Med. 2006;27(4):299–402.

    Article  PubMed  CAS  Google Scholar 

  5. Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest. 2006;116(3):561–70.

    Article  PubMed  CAS  Google Scholar 

  6. Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P. Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer. 2004;11(3):537–51.

    Article  PubMed  CAS  Google Scholar 

  7. Acconcia F, Totta P, Ogawa S, Cardillo I, Inoue S, Leone S, et al. Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signaling. J Cell Physiol. 2005;203(1):193–201.

    Article  PubMed  CAS  Google Scholar 

  8. Koehler KF, Helguero LA, Haldosen LA, Warner M, Gustafsson JA. Reflections on the discovery and significance of estrogen receptor beta. Endocr Rev. 2005;26(3):465–78.

    Article  PubMed  CAS  Google Scholar 

  9. Galluzzo P, Caiazza F, Moreno S, Marino M. Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr Relat Cancer. 2007;14(1):153–67.

    Article  PubMed  CAS  Google Scholar 

  10. Hewitt RE, McMarlin A, Kleiner D, Wersto R, Martin P, Tsokos M, et al. Validation of a model of colon cancer progression. J Pathol. 2000;192(4):446–54.

    Article  PubMed  CAS  Google Scholar 

  11. Witte D, Chirala M, Younes A, Li Y, Younes M. Estrogen receptor beta is expressed in human colorectal adenocarcinoma. Hum Pathol. 2001;32(9):940–4.

    Article  PubMed  CAS  Google Scholar 

  12. Caiazza F, Galluzzo P, Lorenzetti S, Marino M. 17Beta-estradiol induces ERbeta up-regulation via p38/MAPK activation in colon cancer cells. Biochem Biophys Res Commun. 2007;359(1):102–7.

    Article  PubMed  CAS  Google Scholar 

  13. Qiu Y, Waters CE, Lewis AE, Langman MJ, Eggo MC. Oestrogen-induced apoptosis in colonocytes expressing oestrogen receptor beta. J Endocrinol. 2002;174(3):369–77.

    Article  PubMed  CAS  Google Scholar 

  14. Marino M, Acconcia F, Bresciani F, Weisz A, Trentalance A. Distinct nongenomic signal transduction pathways controlled by 17beta-estradiol regulate DNA synthesis and cyclin D(1) gene transcription in HepG2 cells. Mol Biol Cell. 2002;13(10):3720–9.

    Article  PubMed  CAS  Google Scholar 

  15. Fernando RI, Wimalasena J. Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: Ras-dependent nongenomic pathways requiring signaling through ERK and Akt. Mol Biol Cell. 2004;15(7):3266–84.

    Article  PubMed  CAS  Google Scholar 

  16. Marino M, Galluzzo P, Leone S, Acconcia F, Ascenzi P. Nitric oxide impairs the 17beta-estradiol-induced apoptosis in human colon adenocarcinoma cells. Endocr Relat Cancer. 2006;13(2):559–69.

    Article  PubMed  CAS  Google Scholar 

  17. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996;93(12):5925–30.

    Article  PubMed  CAS  Google Scholar 

  18. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, et al. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab. 1997;82(12):4258–65.

    Article  PubMed  CAS  Google Scholar 

  19. Jassam N, Bell SM, Speirs V, Quirke P. Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes’ staging. Oncol Rep. 2005;14(1):17–21.

    PubMed  CAS  Google Scholar 

  20. Wong NA, Malcomson RD, Jodrell DI, Groome NP, Harrison DJ, Saunders PT. ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. J Pathol. 2005;207(1):53–60.

    Article  PubMed  CAS  Google Scholar 

  21. Wang L, Guan X, Gong W, Yao J, Peng Z, Wei D, et al. Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer. Clin Exp Metastasis. 2005;22(3):205–13.

    Article  PubMed  CAS  Google Scholar 

  22. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119(3):493–501.

    Article  PubMed  CAS  Google Scholar 

  23. Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, et al. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer. 2003;39(9):1251–8.

    Article  PubMed  CAS  Google Scholar 

  24. Xie LQ, Yu JP, Luo HS. Expression of estrogen receptor beta in human colorectal cancer. World J Gastroenterol. 2004;10(2):214–7.

    PubMed  CAS  Google Scholar 

  25. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin. 2010;60(5):277–300.

    Google Scholar 

  26. al-Azzawi F, Wahab M. Estrogen and colon cancer: current issues. Climacteric. 2002;5(1):3–14.

    PubMed  CAS  Google Scholar 

  27. Genazzani AR, Gambacciani M, Simoncini T, Schneider HP. Hormone replacement therapy in climacteric and aging brain. International Menopause Society Expert Workshop, 15–18 March 2003, Pisa, Italy. Climacteric. 2003;6(3):188–203.

    PubMed  CAS  Google Scholar 

  28. Giovannucci E. Obesity, gender, and colon cancer. Gut. 2002;51(2):147.

    Article  PubMed  CAS  Google Scholar 

  29. Ziv Y, Gupta MK, Milsom JW, Vladisavljevic A, Kitago K, Fazio VW. The effect of tamoxifen on established human colorectal cancer cell lines in vitro. Anticancer Res. 1996;16(6B):3767–71.

    PubMed  CAS  Google Scholar 

  30. Arai N, Strom A, Rafter JJ, Gustafsson JA. Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein. Biochem Biophys Res Commun. 2000;270(2):425–31.

    Article  PubMed  CAS  Google Scholar 

  31. Kuruppu D, Christophi C, Bertram JF, O’Brien PE. Tamoxifen inhibits colorectal cancer metastases in the liver: a study in a murine model. J Gastroenterol Hepatol. 1998;13(5):521–7.

    Article  PubMed  CAS  Google Scholar 

  32. Campbell-Thompson M, Lynch IJ, Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res. 2001;61(2):632–40.

    PubMed  CAS  Google Scholar 

  33. Castiglione F, Taddei A, Degl’Innocenti DR, Buccoliero AM, Bechi P, Garbini F, et al. Expression of estrogen receptor beta in colon cancer progression. Diagn Mol Pathol. 2008;17(4):231–6.

    Article  PubMed  CAS  Google Scholar 

  34. Linsalata M, Russo F, Notarnicola M, Guerra V, Cavallini A, Clemente C, et al. Effects of genistein on the polyamine metabolism and cell growth in DLD-1 human colon cancer cells. Nutr Cancer. 2005;52(1):84–93.

    Article  PubMed  CAS  Google Scholar 

  35. Hsu HH, Cheng SF, Wu CC, Chu CH, Weng YJ, Lin CS, et al. Apoptotic effects of over-expressed estrogen receptor-beta on LoVo colon cancer cell is mediated by p53 signalings in a ligand-dependent manner. Chin J Physiol. 2006;49(2):110–6.

    PubMed  CAS  Google Scholar 

  36. Wada-Hiraike O, Imamov O, Hiraike H, Hultenby K, Schwend T, Omoto Y, et al. Role of estrogen receptor beta in colonic epithelium. Proc Natl Acad Sci U S A. 2006;103(8):2959–64.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohamed Awad Ebrahim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elbanna, H.G., Ebrahim, M.A., Abbas, A.M. et al. Potential Value of Estrogen Receptor Beta Expression in Colorectal Carcinoma: Interaction with Apoptotic Index. J Gastrointest Canc 43, 56–62 (2012). https://doi.org/10.1007/s12029-010-9214-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-010-9214-4

Keywords

Navigation